单独或与R21结合使用基于纳米粒子CIS43的结点疫苗对疟疾产生保护性免疫力
Prabhanshu Tripathi1, Ja-Hyun Koo2, Xuejun Chen1
1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
bioRxiv : the preprint server for biology
|September 18, 2025
概括
一种针对Plasmodium falciparum circumsporozoite蛋白 (PfCSP) 结节表位的新型疟疾疫苗显示出有希望的结果. 这种基于CIS43的纳米粒子疫苗,单独或与R21结合,扩大了对疟疾的免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 寄生虫学的寄生虫学
背景情况:
- 目前的疟疾疫苗,如RTS,S/AS01和R21/Matrix-M,针对的是Plasmodium falciparum环球体蛋白 (PfCSP) 的主要重复.
- 针对PfCSP结区域的CIS43单克隆抗体显示出高的保护效率,确定该表位是关键的疫苗标.
研究的目的:
- 开发和评估一种新的疟疾疫苗,该疫苗的基础是自组装纳米粒子上呈现的CIS43连接表位的并列重复.
- 通过分析B细胞反应和抗体特异性,单独和与R21疫苗结合,比较这种结点疫苗的免疫性和有效性.
主要方法:
- 开发一种基于纳米粒子的疫苗,该疫苗显示PfCSP结位表位的同时重复.
- 涉及不同剂量 (1微克和0.25微克) 接种结点疫苗和R21疫苗的比较疗效研究.
- 分析B细胞反应和单克隆抗体的分离,以描述疫苗诱导的免疫向.
主要成果:
- 接口疫苗和R21疫苗都显示,在1μg剂量下,疟疾肝脏负担有相似的降低.
- 在0.25μg的剂量下,结点疫苗显示,与R21相比,肝脏负担略有降低.
- 与单独接种任何一种疫苗相比,结合接种和R21疫苗的组合导致了适度增强的保护.
- R21疫苗主要诱导针对主要重复的抗体,而结点疫苗则诱导针对结点和主要重复区域的抗体.
结论:
- 纳米粒子格式的,并联重复的CIS43结点疫苗是扩大抗疟疾免疫力的有希望的策略.
- 这种关键疫苗可以被视为独立的干预措施,或与R21等现有疫苗结合使用,以提高对疟疾的保护.
关键词:
在CIS43中,CIS43是CIS43中的一个.我们的PfCSP.R21 一个人的生活抗体是对抗体的重要组成部分.疟疾 疟疾 是一种疾病.自组装的纳米粒子自组装基于结构的设计设计.疫苗 疫苗 疫苗 疫苗更多相关视频
10:01Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Published on: October 17, 2018
8.5K
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
8.0K
相关概念视频
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...